Molecular cancer therapy: Epithelial-to-Mesenchymal transition protein SNAI2 increases the expression of Cyclin dependent kinase (CDK6) via up regulation of its target gene, 03/October/2014, 11.13 am

Molecular therapy for Human cancer: E6AP ubiquitin-protein ligase inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 03/October/2014, 11.08 am
October 3, 2014
Transcriptional Regulation: Menin (MEN1) decreases the expression of transcriptional coactivator p300 via up regulation of its target gene, 03/October/2014, 11.17 am
October 3, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, Molecular cancer therapy: Epithelial-to-Mesenchymal transition protein SNAI2 increases the expression of Cyclin dependent kinase (CDK6) via up regulation of its target gene, 03/October/2014, 11.13 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that SNAI2, by increasing the expression of its target gene, it may increase the expression of CDK6.  Thus, pharmacological formulations encompassing SNAI2 inhibitors may be used to inhibit tumorigenesis and metastasis.

Comments are closed.